Global Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032
Overview
The Global Circulating Tumor Cells (CTC) Liquid Biopsy Market is expected to reach a 10.36 USD Billion by 2032 and is projected to grow at a CAGR of 23.66% from 2025 to 2032.
Revenue, 2024 (USD Billion)
1.76
Forecast, 2032 (USD Billion)
10.36
CAGR, 2024 - 2032
23.66%
Report Coverage
Global
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market 2018-2032 USD Billion
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 1.76 USD Billion
- Projected Market Size (2032): 10.36 USD Billion
- CAGR (2025-2032): 23.66%
Key Findings of Global Circulating Tumor Cells (CTC) Liquid Biopsy Market
- The Global Circulating Tumor Cells (CTC) Liquid Biopsy Market was valued at 10.36 USD Billion in 2024.
- The Global Circulating Tumor Cells (CTC) Liquid Biopsy Market is likely to grow at a CAGR of 23.66% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Research & Academic Institutes in End User Segment accounted for the largest share of the market with a revenue of 1.56 USD Billion
- The fastest growing segment CTC Detection Methods in Technology Segment grew Fastest with a CAGR of 28.26% during the forecast period from 2024 to 2032.
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Scope
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Segmentation & Scope
Technology
- Immunocytochemical Technologies
- Negative Selection
- Single Spiral Microchannel
- Microchips
- Xenotransplantation Models
- Functional In vitro Cell Invasion Assay
- Molecular (RNA)-Based Technologies
- Ex Vivo Positive Selection
- CTC Enrichment Methods
- CTC Detection Methods
Application
- Multiple Chromosome Abnormalities
- Cancer Stem Cell Research
- Others
End User
- Physician Laboratories
- Hospitals
- Reference Laboratories
- Research & Academic Institutes
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 1.76 USD Billion |
| Market Value in 2032 | 10.36 USD Billion |
| CAGR (2025-2032) | 23.66% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Technology,Application,End User |
Regional Insights:
-
Leading Market (2024-2032): Global, leading in terms of revenue 1.76 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 727.11 USD Million in 2024.
Segments and Scope
-
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032, By Technology
- CTC Detection Methods is the largest segment in Global Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032 with a revenue of 438.44 USD Billion in the year 2024.
- CTC Detection Methods is the Fastest growing segment in Global Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032 with a Growth rate of 28.26 % in forecast period 2025-2032.
-
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032, By Application
- Cancer Stem Cell Research is the largest segment in Global Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032 with a revenue of 621.99 USD Billion in the year 2024.
- Cancer Stem Cell Research is the Fastest growing segment in Global Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032 with a Growth rate of 27.57 % in forecast period 2025-2032.
-
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032, By End User
- Research & Academic Institutes is the largest segment in Global Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032 with a revenue of 1.56 USD Billion in the year 2024.
- Research & Academic Institutes is the Fastest growing segment in Global Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032 with a Growth rate of 24.09 % in forecast period 2025-2032.
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Company Share Analysis
| Company Name |
|
||
| Myriad Genetics, Inc. | |||
| Natera, Inc. | |||
| Illumina, Inc. | |||
| Immucor | |||
| Thermo Fisher Scientific Inc. | |||
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Geographical Sales Distribution, 2018-2032 USD Billion
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Global Circulating Tumor Cells (CTC) Liquid Biopsy Market is segmented based on Segmentation Technology,Application,End User.
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market was valued at USD 1.76(Revenue in USD Billion) in 2020.
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market is projected to grow at a CAGR of 23.66% during the forecast period of 2024 to 2032.
The Research & Academic Institutes segment is expected to dominate the Global Circulating Tumor Cells (CTC) Liquid Biopsy Market, holding a largest market share of 1.56 USD Billion in 2024
Coming Soon....
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Scope
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Segmentation & Scope
Technology
- Immunocytochemical Technologies
- Negative Selection
- Single Spiral Microchannel
- Microchips
- Xenotransplantation Models
- Functional In vitro Cell Invasion Assay
- Molecular (RNA)-Based Technologies
- Ex Vivo Positive Selection
- CTC Enrichment Methods
- CTC Detection Methods
Application
- Multiple Chromosome Abnormalities
- Cancer Stem Cell Research
- Others
End User
- Physician Laboratories
- Hospitals
- Reference Laboratories
- Research & Academic Institutes
Frequently Asked Questions
The Global Circulating Tumor Cells (CTC) Liquid Biopsy Market is segmented based on Segmentation Technology,Application,End User.
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market was valued at USD 1.76(Revenue in USD Billion) in 2020.
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market is projected to grow at a CAGR of 23.66% during the forecast period of 2024 to 2032.
The estimated market value of the Global Circulating Tumor Cells (CTC) Liquid Biopsy Market for final year is USD 10.36 (USD Billion).
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market Company Profiling
Frequently Asked Questions
The Global Circulating Tumor Cells (CTC) Liquid Biopsy Market is segmented based on Segmentation Technology,Application,End User.
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market was valued at USD 1.76(Revenue in USD Billion) in 2020.
Global Circulating Tumor Cells (CTC) Liquid Biopsy Market is projected to grow at a CAGR of 23.66% during the forecast period of 2024 to 2032.
The estimated market value of the Global Circulating Tumor Cells (CTC) Liquid Biopsy Market for final year is USD 10.36 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.